Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 229 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2786 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2022-12-05 | 2023-01-06 | 177132 |
APO-PRAZO TAB 5MG | 5MG | TABLET | Resolved | 2022-12-09 | 2023-01-20 | 177594 |
APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-12-09 | 2023-01-06 | 177603 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2022-12-09 | 2023-01-26 | 177615 |
APO-CEPHALEX | 500MG | TABLET | Resolved | 2022-12-09 | 2023-02-16 | 177678 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2022-12-16 | 2023-01-20 | 178742 |
APO-TRAZODONE D TABLETS 150MG | 150MG | TABLET | Resolved | 2022-12-16 | 2023-04-21 | 178745 |
APO-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2022-12-16 | 2023-01-20 | 178748 |
APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2022-12-16 | 2023-01-06 | 178757 |
APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2022-12-16 | 2022-12-23 | 178760 |
APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2022-12-16 | 2023-01-06 | 178763 |
APO-ABIRATERONE FILM COATED TABLETS | 250MG | TABLET | Resolved | 2022-12-16 | 2023-01-10 | 178769 |
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 1000MG 50MG | TABLET | Resolved | 2022-12-16 | 2023-02-02 | 178778 |
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 1000MG 50MG | TABLET | Resolved | 2022-12-16 | 2023-02-02 | 178781 |
APO-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2022-12-16 | 2023-03-30 | 178784 |
APO-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2022-12-16 | 2023-03-30 | 178787 |
APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2022-12-16 | 2023-03-02 | 178793 |
APO-FLECAINIDE | 50MG | TABLET | Resolved | 2022-12-23 | 2023-01-13 | 179450 |
APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2022-12-23 | 2023-02-17 | 179453 |
APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2022-12-23 | 2023-01-26 | 179456 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
APO-NORTRIPTYLINE | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
APO-NORTRIPTYLINE | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |
APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
APO-AMOXI | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
APO-CLINDAMYCIN | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2019-07-13 | 60399 |